Skip to content
Get in touch

Research › ADHD & Attention

ADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility study

Share

Suggested message

Check out this Knowledge Base article from StressTherapy Solutions: ADHD and EEG-neurofeedback: a double-blind randomized placebo-controlled feasibility study.

Facebook LinkedIn Email

Facebook doesn't let websites fill in your post. Use Copy message, then paste it in.

Study at a glance

Area
ADHD & Attention
Study type
Randomized controlled trial
Authors
Lansbergen MM, van Dongen-Boomsma M, Buitelaar JK, Slaats-Willemse D
Journal
Journal of Neural Transmission
Year
2010
Participants
14
Population
Children, Adolescents
Protocol
SMR up, theta down (vs placebo feedback)
Sessions
30
Equipment
BrainMaster Atlantis

Key findings

  • All children completed the study; no significant side effects
  • ADHD symptoms improved similarly in real and placebo groups
  • Automatically adjusted reward thresholds may limit learning

DOI 10.1007/s00702-010-0524-2 → PubMed 21165661 →

A double-blind, placebo-controlled feasibility study in which children with ADHD were randomly given 30 sessions of individualized neurofeedback or placebo feedback from a simulated EEG. The design proved workable and safe, and ADHD symptoms improved in both groups to a similar degree; the authors adjusted the main trial in light of the results.